OTX-2101

N/A

Report date: 2026/05/06 20:02:28
NME

Base Information

Drug NameOTX-2101
Drug Alias NameOTX-2101
ClassificationCell and gene therapy > Gene therapy > mRNA
Mechanisms of ActionMyc proto-oncogene protein inhibitors
TargetsMyc proto-oncogene protein
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOmega Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesOmega Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A